Preferred Label : Pravastatin;
NCIt synonyms : Pravastatin Base;
NCIt related terms : [1S-[1alpha(betaS*,deltaS*),2alpha,6alpha,8beta(R*),8aalpha]]-1,2,6,7,8,8a-Hexahydro-beta,!d,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1-naphthaleneheptanoic
Acid;
NCIt definition : A synthetic lipid-lowering agent. Pravastatin competitively inhibits hepatic hydroxymethyl-glutaryl
coenzyme A (HMG-CoA) reductase, the enzyme which catalyzes the conversion of HMG-CoA
to mevalonate, a key step in cholesterol synthesis. Pravastatin lowers plasma cholesterol
and lipoprotein levels, and modulates immune responses by suppressing MHC II (major
histocompatibility complex II) on interferon gamma-stimulated, antigen-presenting
cells such as human vascular endothelial cells. (NCI04);
Alternative definition : NCI-GLOSS: The active ingredient in a drug used to lower the amount of cholesterol
in the blood and to prevent stroke and heart attack. It is also being studied in the
treatment of cancer and other conditions. Pravastatin blocks an enzyme that helps
make cholesterol in the body. It may also make tumor cells more sensitive to anticancer
drugs. It is a type of HMG-CoA reductase inhibitor, a type of statin, and a type of
chemosensitizer.;
UNII : KXO2KT9N0G;
InChIKey : TUZYXOIXSAXUGO-PZAWKZKUSA-N;
CAS number : 81093-37-0;
Chemical formula : C23H36O7;
ChEBI ID : CHEBI:63618;
Codes from synonyms : 02539; CDR0000430875; 416;
Origin ID : C62070;
UMLS CUI : C0085542;
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
concept_is_in_subset
has_salt_form
has_target
is_free_acid_or_base_form_of
https://www.cochrane.org/fr/CD013673/HTN_pravastatine-pour-la-reduction-des-lipides
2023
United Kingdom
review of literature
french abstract
Reduction
Reduced
Pravastatin
Lipid
lipids
pravastatin
lipid, nos
pravastatin
---